Novavax Inc (NVAX)
Healthcare
Biotechnology
7.30 $
-1.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -245 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -67 | -126 | -255 | -139 | -185 | -137 | -43 | 323 | -416 | -714 | -87 | -245 | |
| 4.4 | 6.0 | 8.5 | 9.8 | 8.2 | 5.7 | 4.9 | 13 | 29 | 41 | 48 | 28 | |
| 6.1 | 13 | 19 | 20 | 18 | 17 | 128 | 184 | 130 | 85 | 48 | 36 | |
| 5.5 | 14 | 20 | 23 | 11 | 13 | 112 | 176 | 574 | – | – | – | |
| 5.1 | 7.2 | -7.5 | 9.1 | -21 | -24 | 12 | 1,734 | -361 | -377 | 48 | -888 | |
| 7.3 | 18 | 18 | 4.2 | 1.4 | 1.9 | 55 | 57 | 93 | 59 | 13 | 5.6 | |
| -130 | -21 | 28 | 36 | 29 | 38 | -378 | 100 | -93 | -59 | -204 | -78 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | 39 | – | – | – | – | – | |
| 111 | 209 | 3.8 | 65 | 103 | 98 | -39 | 590 | – | – | – | -4.8 | |
| -0.8 | -0.8 | 314 | 0.0 | -96 | -96 | -96 | -128 | 82 | -352 | -4.0 | 33 | |
| 110 | 208 | 279 | 65 | 103 | 98 | 985 | 462 | 325 | 4.5 | 261 | 28 | |
| -87 | 61 | 51 | -38 | -53 | 0.2 | 567 | 880 | -179 | -765 | -39 | -289 | |
| -74 | -144 | -274 | -143 | -186 | -138 | -97 | 265 | -509 | -773 | -100 | -250 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.